Proshrs Ulsht Nq Bio (BIS) 31.24 $BIS Finally A Biotech

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proshrs Ulsht Nq Bio (BIS) 31.24 $BIS

Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 31.24 (-1.07), FBT: 102.69 (+2.43), XBI: 63.57 (+1.50), IBB: 294.07 (+4.63), LABD: 21.57 (-1.62)

Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 31.24 (-1.07), FBT: 102.69 (+2.43), XBI: 63.57 (+1.50), IBB: 294.07 (+4.63), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

BlackIce Completes the Implementation of Basel II Using the ERA Solution with Vietnam International Bank (VIB)
ACCESSWIRE - Wed Mar 30, 10:19PM CDT
VANCOUVER, BC / ACCESSWIRE / March 30, 2016 / BlackIce Enterprise Risk Management (CSE: BIS) ("BlackIce" announces the implementation of the Basel II Project utilizing the BlackIce Enterprise Risk Aggregation (ERA™) solution with the Vietnam International Commercial Bank (VIB).
BIS: 31.24 (-1.07)

The Fed’s LMCI Drops for Second Consecutive Month
Chuck Butler - Daily Reckoning - Tue Mar 08, 9:36AM CST
This post The Fed’s LMCI Drops for Second Consecutive Month appeared first on Daily Reckoning . The Fed's very own Labor Markets Condition Index fell 2.4 points in February - the largest monthly drop since 2009 - despite the so-called...
BIS: 31.24 (-1.07), RBA: 32.90 (-0.30)

Two Big Factors Hurting Biotech ETFs
ETFtrends.com - ETF Trends - Tue Oct 06, 3:39PM CDT
Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday. Biotech sector stocks were among the worst performing areas of the market Tuesday. The iShares Nasdaq...
SBIO: 25.37 (+0.25), BIS: 31.24 (-1.07), FBT: 102.69 (+2.43), PTH: 48.89 (-0.07), IBB: 294.07 (+4.63), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 8:30AM CDT
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
BIS: 31.24 (-1.07), VRX: 20.89 (-1.41), IBB: 294.07 (+4.63), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

Where Do Biotech ETFs Go From Here?
ETFtrends.com - ETF Trends - Tue Sep 29, 2:49PM CDT
Biotechnology stocks and related exchange traded funds gave back all of their gains this year and then some, and the sector may experience even more pain ahead. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by...
BIS: 31.24 (-1.07), IBB: 294.07 (+4.63), RXD: 41.34 (unch), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

How to Short Biotechnology Stocks with ETFs
Sweta Killa - Zacks Investment Research - Tue Sep 29, 9:17AM CDT
Here are the three ETF ways to play the bearish trend in the biotech sector.
BIS: 31.24 (-1.07), VRX: 20.89 (-1.41), IBB: 294.07 (+4.63), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

Guide to Inverse & Leveraged Biotech ETF Investing
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 11:08AM CDT
Understanding the basics of investing in the inverse and leveraged biotech ETFs, depending on market conditions.
BIS: 31.24 (-1.07), BIB: 50.53 (+1.64), UBIO: 31.28 (+1.52), LABU: 45.19 (+3.21), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

Clinton Delivers Poison Pill To Biotech ETFs
ETFtrends.com - ETF Trends - Mon Sep 21, 1:27PM CDT
If you’re on team Hillary Clinton in the upcoming presidential election, you might want to trim down exposure to biotechnology stocks and sector-related exchange traded funds. “Price gouging like this in the specialty drug market is...
SBIO: 25.37 (+0.25), BIS: 31.24 (-1.07), BBC: 20.21 (+0.31), XBI: 63.57 (+1.50), IBB: 294.07 (+4.63), RXD: 41.34 (unch), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

This Is The Week! Finally!
Chuck Butler - Daily Reckoning - Mon Sep 14, 9:26AM CDT
This post This Is The Week! Finally! appeared first on Daily Reckoning . The week is finally here when the FOMC will make a rate decision. Chuck Butler remains steadfast in his call - read on to see if the markets are on board too... The post ...
BIS: 31.24 (-1.07), IP: 45.50 (-0.31)

Impressive Bull Run in Biotech ETFs Causes Some to Take Pause
ETFtrends.com - ETF Trends - Thu Jul 16, 10:00AM CDT
The biotechnology sector and related exchange traded funds are breaking out to new highs, but the rapid ascension has some worried about valuations. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by assets, has...
BIS: 31.24 (-1.07), BIB: 50.53 (+1.64), IBB: 294.07 (+4.63), RXD: 41.34 (unch), LABD: 21.57 (-1.62), ZBIO: 21.11 (-1.10)

What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 31.24 (-1.07)

Volatility in Healthcare ETFs Ahead of Supreme Court’s Obamacare Ruling
ETFtrends.com - ETF Trends - Mon Jun 15, 2:05PM CDT
The Supreme Court will give its ruling on the a key component in Obamacare that could set off short-term selling in the healthcare stocks and sector-related exchange traded funds at the end of the month. The healthcare sector has been among the...
BIS: 31.24 (-1.07), IYH: 157.13 (+1.05), FHLC: 35.89 (+0.24), RXD: 41.34 (unch), LABD: 21.57 (-1.62), VHT: 138.38 (+0.82), XLV: 75.68 (+0.48)

Why I'm Shorting Biotech
George Budwell, The Motley Fool - Motley Fool - Sat Jun 13, 12:16PM CDT
Biotech and biopharma have had an incredible run over the past few years. And like many investors, I've been able to crush the broader markets simply by buying and holding top names in the industry like  AbbVie  ,  Gilead Sciences  , and  Isis...
ESRX: 76.17 (+0.10), BIS: 31.24 (-1.07), ISIS: 57.56 (-0.28), GILD: 80.46 (+0.99), MRK: 58.66 (unch), IBB: 294.07 (+4.63), ABBV: 66.94 (+0.71), BMY: 76.19 (+1.38), CELG: 114.69 (+2.50)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 3

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
PhoenixAI and Cloudera's Strategic Partnership Shifts Data Landscape

Updated Category News Views 8

Time to Embrace Change: PhoenixAI Teams with Cloudera Mention the word 'partnership' in the tech space, and it's often as common as a cup of joe at dawn—but this one truly shakes things up. We're talking about PhoenixAI hitching its wagon to Cloudera's startup circus, a merging of fire and steel in AI-driven database management. With PhoenixAI strutting its stuff on the...

Continue Reading
Aviator Nation Teams with NFL for 2026 Collection Launch

Updated Category News Views 6

In a move blending sports with a dash of retro flair, Aviator Nation's dropping its first NFL-licensed collection. They’re looking to serve up a blend of vintage vibes and team spirit. Aviator Nation's New Venture Launching their collection on September 24th, 2026, Aviator Nation takes a dive deeper into sports licensing, after scoring a touchdown (literally!) with an...

Continue Reading
Spotlight on AI-Powered Smart Homes for 2027

Updated Category News Views 6

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 4

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 6

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 8

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading
AMD CEO, Global Leaders Converge At IMPERIA Summit

Updated Category News Views 4

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 5

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie's TEPKINLY® Shakes Up Follicular Lymphoma Treatment

Updated Category News Views 10

TEPKINLY®'s Game-Changing Approval Your run-of-the-mill trading day just took a wild turn with AbbVie (NYSE: ABBV) flexing some serious muscle in the oncology space. Their biotech brainchild, TEPKINLY® together with lenalidomide and rituximab (R2), snagged approval from the European Commission to tackle relapsed or refractory follicular lymphoma (FL). This ain't no...

Continue Reading
Bittensor Faces Decline: Analyzing Recent Market Trends

Updated Category News Views 64

Bittensor's Recent Price Movements Bittensor's cryptocurrency, known by its ticker TAO/USD, has faced a notable decline of 6.45% in the last 24 hours, bringing its current price down to $510.45. This drop is part of a broader downward trend that has seen the price decrease by 3.0% over the past week, from $526.14 to its present value. Understanding the Market Dynamics To...

Continue Reading
Tenable's Strategic Move with Apex Security Acquisition to Boost Cyber Defense

Updated Category News Views 353

Empowering Cybersecurity Through Strategic Acquisitions Tenable Holdings, Inc., a leader in exposure management, has recently announced its intention to acquire Apex Security, a cutting-edge company dedicated to securing the increasing vulnerabilities associated with artificial intelligence. This strategic move is primarily aimed at enhancing Tenable's capability to...

Continue Reading
AUGA Group Highlights Resilience Amid Restructuring Measures

Updated Category News Views 199

AUGA Group's Interim Financial Results Reflect Strategic Adjustments AUGA Group, RAB, recently reported its consolidated interim unaudited results for a six-month period. Despite undergoing crucial restructuring phases, the Group successfully reduced costs and improved EBITDA to EUR 6.60 million. Financial Overview for the First Half of 2025 As of September 30, 2025, AUGA...

Continue Reading
Leslies Earnings on the Horizon: Brace for Impact

Updated Category News Views 156

Leslies (NASDAQ: LESL) is about to drop its quarterly earnings on February 17, 2026, and traders are bracing for impact. With estimates landing at an earnings per share (EPS) of $-4.43, the stage is set for volatility. It's a classic 'sell the news' scenario hanging over investors' heads like a dark cloud. The last quarter? A disaster—missed by $1.13, and shares took a...

Continue Reading